| 000 | 01829 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513211230.0 | ||
| 264 | 0 | _c20000531 | |
| 008 | 200005s 0 0 eng d | ||
| 022 | _a0250-7005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaytragoon-Lewin, N | |
| 245 | 0 | 0 |
_aAlteration of cellular mediated cytotoxicity, T cell receptor zeta (TcR zeta) and apoptosis related gene expression in nasopharyngeal carcinoma (NPC) patients: possible clinical relevance. _h[electronic resource] |
| 260 |
_bAnticancer research _c |
||
| 300 |
_a1093-100 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 |
_aCarrier Proteins _xanalysis |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCytoskeletal Proteins |
| 650 | 0 | 4 | _aCytotoxicity, Immunologic |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aGenes, T-Cell Receptor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 |
_aInterferons _xtherapeutic use |
| 650 | 0 | 4 |
_aInterleukin-2 _xbiosynthesis |
| 650 | 0 | 4 | _aIntracellular Signaling Peptides and Proteins |
| 650 | 0 | 4 |
_aKeratins _xanalysis |
| 650 | 0 | 4 | _aLIM Domain Proteins |
| 650 | 0 | 4 |
_aLymphocytes _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNasopharyngeal Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aReceptors, Antigen, T-Cell _xgenetics |
| 700 | 1 | _aPorwit-MacDonald, A | |
| 700 | 1 | _aMellstedt, H | |
| 700 | 1 | _aLewin, F | |
| 773 | 0 |
_tAnticancer research _gvol. 20 _gno. 2B _gp. 1093-100 |
|
| 999 |
_c10762243 _d10762243 |
||